Literature DB >> 17994201

[Peritoneal carcinomatosis in ovarian cancer. Methods and treatment results].

J Pfisterer1, P Harter, F Hilpert, A du Bois.   

Abstract

Epithelial ovarian cancer is the gynecological tumor with the highest mortality rate. Numerous findings have recently emerged about the value and extent of surgical therapy of this disease. Already applied to national and international standards and guidelines, these new developments must become part of clinical practice if patients are to benefit.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17994201     DOI： 10.1007/s00104-007-1431-4

Source DB:  PubMed          Journal:  Chirurg        ISSN： 0009-4722            Impact factor:   0.955


  17 in total

1.  Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.

Authors:  Giovanni D Aletti; Sean C Dowdy; Bobbie S Gostout; Monica B Jones; C Robert Stanhope; Timothy O Wilson; Karl C Podratz; William A Cliby
Journal:  Obstet Gynecol       Date:  2006-01       Impact factor: 7.661

2.  Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

Authors:  Deborah K Armstrong; Brian Bundy; Lari Wenzel; Helen Q Huang; Rebecca Baergen; Shashikant Lele; Larry J Copeland; Joan L Walker; Robert A Burger
Journal:  N Engl J Med       Date:  2006-01-05       Impact factor: 91.245

3.  Outcomes for systemic therapy in women with ovarian cancer.

Authors:  L Elit; C Chartier; A Oza; H Hirte; M Levine; L Paszat
Journal:  Gynecol Oncol       Date:  2006-05-24       Impact factor: 5.482

4.  Colorectal resection in patients with ovarian and primary peritoneal carcinoma.

Authors:  Stephen J Tebes; Richard Cardosi; Mitchel S Hoffman
Journal:  Am J Obstet Gynecol       Date:  2006-05-30       Impact factor: 8.661

5.  Secondary surgical cytoreduction for advanced ovarian carcinoma.

Authors:  Peter G Rose; Stacy Nerenstone; Mark F Brady; Daniel Clarke-Pearson; George Olt; Stephen C Rubin; David H Moore; James M Small
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

6.  The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.

Authors:  Eric L Eisenhauer; Nadeem R Abu-Rustum; Yukio Sonoda; Douglas A Levine; Elizabeth A Poynor; Carol Aghajanian; William R Jarnagin; Ronald P DeMatteo; Michael I D'Angelica; Richard R Barakat; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2006-08-04       Impact factor: 5.482

7.  The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer.

Authors:  M E van der Burg; M van Lent; M Buyse; A Kobierska; N Colombo; G Favalli; A J Lacave; M Nardi; J Renard; S Pecorelli
Journal:  N Engl J Med       Date:  1995-03-09       Impact factor: 91.245

8.  What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?

Authors:  S M Eisenkop; N M Spirtos
Journal:  Gynecol Oncol       Date:  2001-09       Impact factor: 5.482

9.  Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study.

Authors:  Lari B Wenzel; Helen Q Huang; Deborah K Armstrong; Joan L Walker; David Cella
Journal:  J Clin Oncol       Date:  2007-02-01       Impact factor: 44.544

10.  Diaphragm resection for ovarian cancer: technique and short-term complications.

Authors:  William Cliby; Sean Dowdy; Simone S Feitoza; Bobbie S Gostout; Karl C Podratz
Journal:  Gynecol Oncol       Date:  2004-09       Impact factor: 5.482
View more
  1 in total

Review 1.  [Surgical treatment of peritoneal metastases from gynecological primary tumors].

Authors:  P Horvath; A Königsrainer
Journal:  Chirurg       Date:  2018-09       Impact factor: 0.955
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.